News | April 19, 2025
Aptar commences clinical study to accelerate FDA approval of SmartTrack
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Potential of Ayurveda’s contribution in global health system through various innovative practices
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Automated parallel capillary electrophoresis system simplifies protein analysis
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Subscribe To Our Newsletter & Stay Updated
